Apcer Life Sciences

Apcer Life Sciences is a specialized, service-oriented company providing critical outsourced functions in drug safety, regulatory affairs, and medical communications to biopharmaceutical clients globally. Its core business model revolves around offering integrated pharmacovigilance, medical information, and regulatory compliance services, enabled by technology and a team of healthcare professionals. The company positions itself as a flexible and cost-effective partner, helping clients navigate complex global regulations from clinical development through post-marketing. With a focus on advanced therapies and a strong track record evidenced by client testimonials, Apcer caters to a growing market demand for specialized regulatory and safety expertise.

Integrated service delivery model enabled by pharmacovigilance databases, medical information response systems, regulatory tracking tools, and quality management software.

Apcer competes in a fragmented market with large, full-service Contract Research Organizations (CROs) like IQVIA and Parexel, other specialized pharmacovigilance service providers, and the in-house departments of large pharmaceutical companies. Its differentiation is based on a focused, integrated service offering, flexibility, and specialized expertise in areas like advanced therapies and medical devices.